Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton

Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton Synthesis and biological evaluation of 1,6-bis-triazole-2,3,4-tri-O-benzyl-α-d-glucopyranosides as a novel α-glucosidase inhibitor in the treatment of Type 2 diabetes Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors Molecular docking studies and synthesis of novel bisbenzimidazole derivatives as inhibitors of α-glucosidase Syntheses of new 3-thiazolyl coumarin derivatives, in vitro α -glucosidase inhibitory activity, and molecular modeling studies Design, synthesis, in vitro, and in silico studies of novel diarylimidazole-1,2,3-triazole hybrids as potent α-glucosidase inhibitors Synthesis of quinoline derivatives as diabetic II inhibitors and molecular docking studies Design, synthesis and docking study of novel tetracyclic oxindole derivatives as α-glucosidase inhibitors Synthesis, α-glucosidase inhibition and molecular docking studies of novel thiazolidine-2,4-dione or rhodanine derivatives Synthesis, α-glucosidase inhibitory and molecular docking studies of prenylated and geranylated flavones, isoflavones and chalcones